mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0005 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.001 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.001 |